Colon Targeted Novel Drug Delivery Systems
(Sprache: Englisch)
The objective of the present study was directed towards developing a colon specific drug delivery system of aceclofenac, the non-steroidal anti-inflammatory drug associated with circadian rhythm of chronobiological symptoms for effective management of...
Leider schon ausverkauft
versandkostenfrei
Buch
74.90 €
Produktdetails
Produktinformationen zu „Colon Targeted Novel Drug Delivery Systems “
Klappentext zu „Colon Targeted Novel Drug Delivery Systems “
The objective of the present study was directed towards developing a colon specific drug delivery system of aceclofenac, the non-steroidal anti-inflammatory drug associated with circadian rhythm of chronobiological symptoms for effective management of rheumatoid arthritis. Aceclofenac is a cox 2 selective inhibitor and has better safety than conventionalnon-steroidal anti-inflammatory drugs with respect to adverse effects on gastrointestinal and cardiovascular system. Aceclofenac is rapidly and completely absorbed after oral administration. Peak plasma concentration reaches in 1-3 h after an oral dose. The plasma elimination half life of the drug is approximately 4 h. The chronopharmacological approach for the management of rheumatoid arthritis has been well documented. Considering this factor, aceclofenac under investigation in the present study was developed as a colon targeted delivery system through tablets, pellets and microspheres. Additionally a Pulsincap drug delivery of the drug was also studied to meet the objective of circadian rhythm in rheumatoid arthritis.
Bibliographische Angaben
- Autoren: S. K. Uma Devi , N. Narayanan , K. Jaya Raja Kumar
- 2016, 276 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3659403644
- ISBN-13: 9783659403644
Sprache:
Englisch
Kommentar zu "Colon Targeted Novel Drug Delivery Systems"
0 Gebrauchte Artikel zu „Colon Targeted Novel Drug Delivery Systems“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Colon Targeted Novel Drug Delivery Systems".
Kommentar verfassen